Nanotechnology & Biopharmaceutics (NanoBioPharm) Research Group

Using the potential of biological nanostructures to create novel drugs and materials and address unmet therapeutic needs.

The NanoBioPharm Lab investigates the potential of self-assembled biological nanostructures to create novel drugs and materials. The team has contributed to the discovery and development of new “nano-drugs” against various diseases, including new antibiotics to fight microbial resistance and new anticancer treatments improving patient convenience.

Key research areas

Bionanomaterials

Self-assembled nanostructures

Biological therapeutics (peptides, proteins)

Drug Delivery Systems (DDS)

Rational drug discovery

Pre-clinical Research

Biophysics

Featured projects

Drug discovery: rational design of biological antibiotics

Rational design of ultrashort self-assembling antimicrobial peptides: structure-function relationship, mechanism of action and therapeutic applications. Lead researcher - Priscila Cardoso

 

Fundamental research

Functional and toxic amyloid nanostructures: structure elucidation, interactions with biomolecules and applications in bio-nanotechnology. Lead researcher - Dr Durga Dharmadana

 

Pre-clinical and translational research

Delivery of therapeutic peptides and proteins. Lead researcher - Dr Jamie Strachan in collaboration with Prof Charlotte Conn (RMIT).

 

Industry service research

Biophysical and physicochemical characterisation of pharmaceutical formulations. NanoBiopharm team’s technical expertise.

 

Peptide composite materials for biomedical applications

Bio-inorganic materials for drug delivery and bio-sensing. Lead researcher: Mr Brody McDonald

 

Meet all our researchers

Meet all our researchers

Our members are expert researchers in their field
Publications

Publications

Find out more about some of the recent publications written by our researchers.

Get in touch

If you would like to learn more about us, or if you are interested in collaborations, please contact lab head Dr Celine Valery.

Abstract DNA technology. Science medical concept

Translational Immunology and Nanotechnology

Our research group sits within the ‘Translational Immunology and Nanotechnology’ (TIN) Theme. This theme was created to drive innovation in omics/precision medicine, nanotechnology and point-of-care devices.

aboriginal flag
torres strait flag

Acknowledgement of Country

RMIT University acknowledges the people of the Woi wurrung and Boon wurrung language groups of the eastern Kulin Nation on whose unceded lands we conduct the business of the University. RMIT University respectfully acknowledges their Ancestors and Elders, past and present. RMIT also acknowledges the Traditional Custodians and their Ancestors of the lands and waters across Australia where we conduct our business - Artwork 'Sentient' by Hollie Johnson, Gunaikurnai and Monero Ngarigo.

aboriginal flag
torres strait flag

Acknowledgement of Country

RMIT University acknowledges the people of the Woi wurrung and Boon wurrung language groups of the eastern Kulin Nation on whose unceded lands we conduct the business of the University. RMIT University respectfully acknowledges their Ancestors and Elders, past and present. RMIT also acknowledges the Traditional Custodians and their Ancestors of the lands and waters across Australia where we conduct our business.